Patents by Inventor Michael BIERMER

Michael BIERMER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS D VIRUS INFECTION
    Publication number: 20210403908
    Abstract: Described are RNA interference (RNAi) agents for treating a Hepatitis D Virus (HDV) infection in a subject in need thereof.
    Type: Application
    Filed: June 22, 2021
    Publication date: December 30, 2021
    Inventors: Ronald Cornelis Marie Kalmeijer, Michael Biermer, Oliver Lenz, Maria Gloria Beumont, Heather Lynn Davis, Thomas Naoki Kakuda
  • COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
    Publication number: 20210285000
    Abstract: Described are RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B Virus (HBV) used in combination with a capsid assembly modulator (CAM) and an interferon, and methods of administering same. The HBV RNAi agents, CAMs and interferon are administered to effectively inhibit HBV gene expression and to treat diseases and conditions associated with HBV infection, particularly in immune tolerant subjects.
    Type: Application
    Filed: March 4, 2021
    Publication date: September 16, 2021
    Inventors: Ronald Cornelis Marie KALMEIJER, Michael BIERMER, Oliver LENZ, Heather Lynn DAVIS, Cristiana MAYER
  • COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
    Publication number: 20200330499
    Abstract: Described are RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B Virus (HBV) used in combination with a capsid assembly modulator (CAM) and methods of administering same. The HBV RNAi agents and CAMs are administered in ratios to effectively inhibit HBV gene expression and to treat diseases and conditions associated with HBV infection.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 22, 2020
    Applicant: Janssen Pharmaceuticals, Inc.
    Inventors: Michael BIERMER, Ronald KALMEIJER, Oliver LENZ, Maria Gloria BEUMONT-MAUVIEL, Jan SNOEYS, Kenneth Alan SIMMEN
  • COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION
    Publication number: 20200332297
    Abstract: Described are RNA interference (RNAi) agents for inhibiting the expression of Hepatitis B Virus (HBV) used in combination with a capsid assembly modulator (CAM) and methods of administering same. The HBV RNAi agents and CAMs are administered in ratios to effectively inhibit HBV gene expression and to treat diseases and conditions associated with HBV infection.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 22, 2020
    Applicant: Janssen Pharmaceuticals, Inc.
    Inventors: Michael BIERMER, Ronald KALMEIJER, Oliver LENZ, Maria Gloria BEUMONT-MAUVIEL, Jan SNOEYS, Kenneth Alan SIMMEN